South Korea approves Novavax COVID-19 vaccine

US-based Novavax, Inc. and SK bioscience, Co. Limited, a vaccine business subsidiary of Korea-based SK Group, have annou...

January 13, 2022 | Thursday | News
Novavax, Serum Institute of India file for COVID-19 vaccine EUA in South Africa

Novavax, Inc. and Serum Institute of India have announced a regulatory submission to the South African Health Products R...

January 11, 2022 | Tuesday | News
GSK Singapore launches Shingrix vaccine against shingles (herpes zoster)

GlaxoSmithKline (GSK) Singapore has launched a new vaccine to help protect against shingles, Shingrix, in...

January 10, 2022 | Monday | News
Pfizer receives EUA of booster shot for 12-15 age group

Pfizer Inc. and BioNTech SE have announced that the U.S. Food and Drug Administration (FDA) has expanded the Emergency U...

January 4, 2022 | Tuesday | News
India's COVAXINÒ exhibits safety in paediatric subjects in Ph II/III study

Indian firm Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines...

January 3, 2022 | Monday | News
CEPI backs Korea to develop ‘variant-proof’ vaccine candidate

Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and South Korean firm SK bioscience (SK) have an...

December 22, 2021 | Wednesday | News
Japan approves booster shot for Moderna COVID-19 vaccine

US-based Brand Institute has announced its successful partnership with Moderna in naming their mRNA COVID-19 vaccine: SP...

December 20, 2021 | Monday | News
Korea issues marketing authorization to Moderna COVID-19 vaccine

American firm Moderna has announced that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing aut...

December 16, 2021 | Thursday | News
HDT Bio initiates RNA COVID-19 vaccine trials in South Korea

HDT Bio Corp., a US-based developer of immunotherapies for oncology and infectious diseases, and Korean biotech Quratis ...

December 14, 2021 | Tuesday | News
Moderna to bring mRNA manufacturing to Australia

US-based Moderna, Inc. has announced an agreement in principle with the Australian Government to build a state-of-the-ar...

December 14, 2021 | Tuesday | News
Hong Kong studies impact of Pfizer vaccine on Omicron variant

A recent study jointly conducted by the LKS Faculty of Medicine, The University of Hong Kong (HKUMed) and the Faculty of...

December 13, 2021 | Monday | News
China’s CanSinoBIO to bring world's first inhalable COVID-19 vaccine

After months of collaborative development, Ireland-based Aerogen and China’s CanSinoBIO have announced a developme...

December 10, 2021 | Friday | News
Japan’s Shionogi to develop COVID-19 recombinant protein-based vaccine

Japan-based Shionogi & Co. has recently announced the results from the Japanese Phase 1/2 clinical trial of S-268019...

December 8, 2021 | Wednesday | News
Korea launches new prestigious award for vaccine industry

The International Vaccine Institute (IVI) is joining hands with SK bioscience, a leading biopharmaceutical company in So...

December 7, 2021 | Tuesday | News
Victoria makes Australia’s first mRNA vaccine candidate

Victorian scientists and manufacturers have created Australia’s first mRNA COVID-19 vaccine candidate – Aust...

December 6, 2021 | Monday | News
Taiwan explores mix-and-match booster trial of COVID-19 vaccines

The Coalition for Epidemic Preparedness Innovations (CEPI) and Taiwan-based Medigen Vaccine Biologics Corp. (MVC) will c...

December 6, 2021 | Monday | News
GenScript, BioComo accelerate novel intranasal SARS-CoV-2 vaccine development in Japan

GenScript Biotech Corporation, a leading global biotechnology company, and BioComo Incorporation, a drug discovery ventu...

December 2, 2021 | Thursday | News
Prestige BioPharma opens global-scale vaccine centre in South Korea

Prestige BioPharma (PBP), a Singapore-based biopharmaceutical with operations in USA and South Korea, has announced the ...

December 1, 2021 | Wednesday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls